Lanean...
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
Liver fibrosis represents a response to chronic liver injury. Metabolic dysfunction-associated fatty liver disease and metabolic dysfunction-associated steatohepatitis are the most common chronic liver diseases, both with increasing incidence. Therefore, there is a great impetus for development of a...
Gorde:
| Argitaratua izan da: | J Clin Transl Hepatol |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
XIA & HE Publishing Inc.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868700/ https://ncbi.nlm.nih.gov/pubmed/33604256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2020.00040 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|